PortfoliosLab logoPortfoliosLab logo
5-stocks Group 7
Performance
Return for Risk
Dividends
Drawdowns
Volatility
Diversification

Asset Allocation


EMB 20.00%SXRM.DE 20.00%NVDA 20.00%BYDDF 20.00%MRNA 20.00%BondBondEquityEquity

S&P 500 Index

Performance

Performance Chart

The chart shows the growth of an initial investment of $10,000 in 5-stocks Group 7, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends. The portfolio is rebalanced Every 3 months.


Loading graphics...

The earliest data available for this chart is Dec 7, 2018, corresponding to the inception date of MRNA

Returns By Period


1D1MYTD6M1Y3Y*5Y*10Y*
Benchmark
S&P 500 Index
0.11%-4.18%-3.84%-1.98%21.98%16.86%10.37%12.29%
Portfolio
5-stocks Group 7
-0.19%-4.41%13.96%12.71%32.47%16.78%18.38%
NVDA
NVIDIA Corporation
0.93%-3.08%-4.88%-5.44%74.29%85.17%66.71%70.07%
BYDDF
BYD Company Limited
-0.37%8.51%9.55%-4.02%-13.21%12.84%13.23%22.94%
MRNA
Moderna, Inc.
-1.66%-14.88%66.84%72.69%91.22%-32.43%-17.98%
EMB
iShares J.P. Morgan USD Emerging Markets Bond ETF
0.12%-2.52%-1.09%1.24%10.04%8.40%1.88%3.24%
SXRM.DE
iShares USD Treasury Bond 7-10yr UCITS ETF (Acc)
0.03%-1.33%-0.14%0.72%4.13%2.30%-0.57%0.88%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Monthly Returns

Based on dividend-adjusted daily data since Dec 10, 2018, 5-stocks Group 7's average daily return is +0.12%, while the average monthly return is +2.49%. At this rate, your investment would double in approximately 2.3 years.

Historically, 62% of months were positive and 38% were negative. The best month was Nov 2020 with a return of +28.8%, while the worst month was Jan 2022 at -13.7%. The longest winning streak lasted 9 consecutive months, and the longest losing streak was 4 months.

On a daily basis, 5-stocks Group 7 closed higher 54% of trading days. The best single day was Mar 16, 2022 with a return of +7.7%, while the worst single day was Mar 9, 2020 at -8.9%.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
202610.62%4.51%-0.81%-0.62%13.96%
2025-2.06%4.92%-2.38%-0.95%4.42%5.20%2.92%-4.97%3.99%1.61%-3.89%3.32%12.01%
20241.16%6.61%7.65%0.19%12.65%0.39%0.21%-5.19%2.96%-2.54%-4.10%-0.95%19.13%
202313.56%-3.73%10.17%-1.93%6.09%3.54%4.06%-2.54%-5.90%-7.46%3.03%8.14%27.67%
2022-13.70%-2.05%0.82%-12.14%7.31%-1.20%6.30%-11.79%-11.84%5.67%14.02%-3.69%-23.83%
202115.04%-6.16%-8.17%10.17%4.67%17.77%10.67%6.13%-3.03%5.94%8.68%-9.89%59.08%

Benchmark Metrics

5-stocks Group 7 has an annualized alpha of 21.38%, beta of 0.75, and R² of 0.33 versus S&P 500 Index. Calculated based on daily prices since December 10, 2018.

  • This portfolio captured 111.48% of S&P 500 Index gains but only 40.90% of its losses — a favorable profile for investors.
  • R² of 0.33 means the benchmark explains less than half of this portfolio's behavior — treat beta with caution or consider switching to a more representative benchmark.

Alpha
21.38%
Beta
0.75
0.33
Upside Capture
111.48%
Downside Capture
40.90%

Expense Ratio

5-stocks Group 7 has an expense ratio of 0.09%, which is considered low. Below, you can find the expense ratios of the portfolio's funds side by side and easily compare their relative costs.


Return for Risk

Risk / Return Rank

5-stocks Group 7 ranks 51 for risk / return — on par with similar portfolios. You're getting a typical balance of risk and reward. Not a standout, but not a red flag either — a reasonable choice if other factors align with your goals.


5-stocks Group 7 Risk / Return Rank: 5151
Overall Rank
5-stocks Group 7 Sharpe Ratio Rank: 4949
Sharpe Ratio Rank
5-stocks Group 7 Sortino Ratio Rank: 5656
Sortino Ratio Rank
5-stocks Group 7 Omega Ratio Rank: 3434
Omega Ratio Rank
5-stocks Group 7 Calmar Ratio Rank: 8080
Calmar Ratio Rank
5-stocks Group 7 Martin Ratio Rank: 3535
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

Return / Risk — by metrics


PortfolioBenchmarkDifference

Sharpe ratio

Return per unit of total volatility

1.23

0.88

+0.35

Sortino ratio

Return per unit of downside risk

1.90

1.37

+0.53

Omega ratio

Gain probability vs. loss probability

1.23

1.21

+0.02

Calmar ratio

Return relative to maximum drawdown

2.94

1.39

+1.55

Martin ratio

Return relative to average drawdown

6.62

6.43

+0.19


How much return does each position deliver for the risk it carries? Higher values mean better reward for the risk taken.

Risk / Return RankSharpe ratioSortino ratioOmega ratioCalmar ratioMartin ratio
NVDA
NVIDIA Corporation
811.472.171.273.027.54
BYDDF
BYD Company Limited
25-0.37-0.270.97-0.37-0.57
MRNA
Moderna, Inc.
751.181.931.232.294.71
EMB
iShares J.P. Morgan USD Emerging Markets Bond ETF
691.351.911.282.078.24
SXRM.DE
iShares USD Treasury Bond 7-10yr UCITS ETF (Acc)
290.751.061.140.691.89

Sharpe Ratio

The Sharpe ratio helps investors understand how much return they're getting for the level of risk taken. A higher Sharpe ratio indicates better risk-adjusted performance, meaning more reward for each unit of risk.

5-stocks Group 7 Sharpe ratios as of Apr 3, 2026 (values are recalculated daily):

  • 1-Year: 1.23
  • 5-Year: 0.75
  • All Time: 1.16

These values reflect how efficiently the investment has delivered returns relative to its volatility over different time periods. All figures are annualized and based on daily total returns (including price changes and dividends).

Compared to the broad market, where average Sharpe ratios range from 0.98 to 1.66, this portfolio's current Sharpe ratio falls between the 25th and 75th percentiles. This indicates that its risk-adjusted performance is in line with the majority of portfolios, suggesting a balanced approach to risk and return—likely suitable for a wide range of investors.

The chart below shows the rolling Sharpe ratio of 5-stocks Group 7 compared to the selected benchmark. This view highlights how the investment's risk-adjusted performance has changed over time.


Loading graphics...

Dividends

Dividend yield

5-stocks Group 7 provided a 2.14% dividend yield over the last twelve months.


TTM20252024202320222021202020192018201720162015
Portfolio2.14%2.21%1.35%1.07%1.04%0.80%0.81%1.07%1.22%1.37%1.06%1.21%
NVDA
NVIDIA Corporation
0.02%0.02%0.03%0.03%0.11%0.05%0.12%0.27%0.46%0.29%0.45%1.20%
BYDDF
BYD Company Limited
5.51%6.04%1.28%0.58%0.07%0.07%0.03%0.58%0.00%2.03%0.00%0.00%
MRNA
Moderna, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
EMB
iShares J.P. Morgan USD Emerging Markets Bond ETF
5.15%4.98%5.46%4.74%5.04%3.89%3.88%4.51%5.64%4.54%4.83%4.84%
SXRM.DE
iShares USD Treasury Bond 7-10yr UCITS ETF (Acc)
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


Loading graphics...

Worst Drawdowns

The table below displays the maximum drawdowns of the 5-stocks Group 7. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the 5-stocks Group 7 was 42.28%, occurring on Oct 11, 2022. Recovery took 365 trading sessions.

The current 5-stocks Group 7 drawdown is 4.41%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-42.28%Nov 30, 2021224Oct 11, 2022365Mar 11, 2024589
-22.47%Feb 12, 202117Mar 8, 202164Jun 7, 202181
-22.1%Jun 6, 2024217Apr 8, 202575Jul 23, 2025292
-19.92%May 3, 201975Aug 15, 2019105Jan 13, 2020180
-17.09%Mar 3, 20208Mar 12, 202022Apr 14, 202030

Volatility

Volatility Chart

The chart below shows the rolling one-month volatility.


Loading graphics...

Diversification

Diversification Metrics


Number of Effective Assets

The portfolio contains 5 assets, with an effective number of assets of 5.00, reflecting the diversification based on asset allocation. This number of effective assets suggests a highly concentrated portfolio, where a few assets dominate the allocation, potentially increasing the portfolio's risk due to lack of diversification.

Asset Correlations Table

The table below displays the correlation coefficients between the individual components of the portfolio, the entire portfolio, and the chosen benchmark.

BenchmarkSXRM.DEBYDDFMRNAEMBNVDAPortfolio
Benchmark1.00-0.050.330.310.520.680.58
SXRM.DE-0.051.00-0.080.070.40-0.040.07
BYDDF0.33-0.081.000.160.220.290.58
MRNA0.310.070.161.000.200.250.73
EMB0.520.400.220.201.000.340.40
NVDA0.68-0.040.290.250.341.000.66
Portfolio0.580.070.580.730.400.661.00
The correlation results are calculated based on daily price changes starting from Dec 10, 2018